MicroRNA 375 and diabetes: A key regulator of β cell function and a promising non-invasive biomarker

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 10

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-1)

Sum=67

Publishing Process of This Article

Item

Count

Browse

Download

Sum=37

Oct 15, 2025 (publication date) through Oct 22, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. Oct 15, 2025; 16(10): 110097
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.110097

Table 1 Main evidence of the modulation of circulating miR-375 in diabetes

Type	Extraction method	Source	Level	Ref.
T1D	miRNeasy serum/plasma kit	Plasma	Up	[73]
	miRCURY RNA isolation kit	Plasma	Up	[74]
	NA	Serum	Up	[75]
	miRNeasy mini kit	Exosome	Up	[70]
	TRIzol	Serum	Down	[76]
	miRNeasy mini kit	Blood	Down	[66]
T2D	miRNeasy serum/plasma kit	Plasma	Up	[59]
	miRNeasy mini kit	Plasma	Up	[60]
	QIAzol and miRNeasy kit	Plasma	Up	[80]
	miRNeasy mini kit	Exosome	Up	[70]
	QIAamp circulating nucleic acid kit	Serum	Up	[78]
	TRIzol	Serum	Up/down¹	[79]
	mirVana^TM miRNA isolation kit	Plasma	Down	[83]
	miRCURY RNA isolation kit	Urinary EVs	Down	[84]
Pre-T2D	miRNeasy mini kit	Plasma	Down	[81]
	mirVana^TM miRNA isolation kit	Plasma	Down	[83]
	Rneasy serum/plasma advanced kit	Serum	Down	[82]

¹Down: In the presence of nephropathy and diabetic foot.

T1D: Type 1 diabetes; T2D: Type 2 diabetes; NA: Not available; miRNA: MicroRNA; EVs: Extracellular vesicles.

Citation: Pierantoni M, Dell’Aira M, Grassilli S, Brugnoli F, Bertagnolo V. MicroRNA 375 and diabetes: A key regulator of β cell function and a promising non-invasive biomarker. World J Diabetes 2025; 16(10): 110097
URL: https://www.wjgnet.com/1948-9358/full/v16/i10/110097.htm
DOI: https://dx.doi.org/10.4239/wjd.v16.i10.110097